Advances in electrocardiograms : methods and analysis / / edited by Richard Millis |
Autore | Millis Richard M |
Pubbl/distr/stampa | IntechOpen, 2012 |
Descrizione fisica | 1 online resource (404 pages) : illustrations |
Disciplina | 616.1207547 |
Soggetto topico | Electrocardiography |
Soggetto non controllato | Cardiovascular medicine |
ISBN | 953-51-6762-6 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Advances in electrocardiograms |
Record Nr. | UNINA-9910138269803321 |
Millis Richard M | ||
IntechOpen, 2012 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Advances in electrocardiograms : clinical applications / / edited by Richard Millis |
Autore | Millis Richard M |
Pubbl/distr/stampa | IntechOpen, 2012 |
Descrizione fisica | 1 online resource (342 pages) : illustrations |
Disciplina | 616.1207547 |
Soggetto topico | Electrocardiography |
Soggetto non controllato | Cardiovascular medicine |
ISBN | 953-51-6757-X |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Advances in electrocardiograms |
Record Nr. | UNINA-9910138270003321 |
Millis Richard M | ||
IntechOpen, 2012 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Aspects of pacemakers : functions and interactions in cardiac and non-cardiac indications / / edited by Oliver Vonend, Siegfried Eckert |
Autore | Vonend Oliver |
Pubbl/distr/stampa | IntechOpen, 2011 |
Descrizione fisica | 1 online resource (208 pages) |
Disciplina | 616.12028 |
Soggetto topico | Cardiac intensive care |
Soggetto non controllato | Cardiovascular medicine |
ISBN | 953-51-6488-0 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Aspects of Pacemakers |
Record Nr. | UNINA-9910138295703321 |
Vonend Oliver | ||
IntechOpen, 2011 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Evidence-based Positron Emission Tomography : Summary of Recent Meta-analyses on PET / / edited by Giorgio Treglia, Luca Giovanella |
Autore | Treglia Giorgio |
Edizione | [1st ed. 2020.] |
Pubbl/distr/stampa | Springer Nature, 2020 |
Descrizione fisica | 1 online resource (VIII, 143 p. 2 illus.) |
Disciplina |
616.07548
616.07575 |
Soggetto topico |
Nuclear medicine
Radiology Oncology Cardiology Neurology Endocrinology Nuclear Medicine Diagnostic Radiology Oncology Neurology Endocrinology Tomografia per emissió de positrons Medicina clínica Medicina basada en l'evidència |
Soggetto genere / forma | Llibres electrònics |
Soggetto non controllato |
Nuclear Medicine
Diagnostic Radiology Oncology Cardiology Neurology Endocrinology Radiology Internal Medicine Open Access Meta-analysis Diagnosis Tumor Infection Nuclear medicine Cardiovascular medicine Neurology & clinical neurophysiology |
ISBN | 3-030-47701-0 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | Section A: Introduction -- 1: Introduction to different PET radiopharmaceuticals and hybrid modalities (PET/CT & PET/MRI) -- 2: A practical guideline on diagnostic and prognostic meta-analyses -- Section B: Evidence-based PET in Oncology -- 3: Evidence-based PET for brain and head/neck tumours -- 4: Evidence-based PET for thoracic tumours -- 5: Evidence-based PET for abdominal and pelvic tumours -- 6: Evidence-based PET for cutaneous, musculoskeletal tumours -- 7: Evidence-based PET for haematological tumours -- 8: Evidence-based PET for endocrine tumours and disorders -- Section C: Evidence-based PET in Cardiology -- 9: Evidence-based PET for cardiac diseases -- Section D: Evidence-based PET in Infection & Inflammation -- 10: Evidence-based PET for infectious and inflammatory diseases -- Section E: Evidence-based PET in Neurology -- 11: Evidence-based PET for neurological diseases. |
Record Nr. | UNINA-9910407724603321 |
Treglia Giorgio | ||
Springer Nature, 2020 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Good Research Practice in Non-Clinical Pharmacology and Biomedicine / / edited by Anton Bespalov, Martin C. Michel, Thomas Steckler |
Autore | Bespalov Anton |
Edizione | [1st ed. 2020.] |
Pubbl/distr/stampa | Springer Nature, 2020 |
Descrizione fisica | 1 online resource (X, 423 p. 34 illus., 21 illus. in color.) |
Disciplina |
615
615.1072 |
Collana | Handbook of Experimental Pharmacology |
Soggetto topico |
Pharmacology
Neurosciences Cardiology Oncology Pharmacology/Toxicology Oncology |
Soggetto non controllato |
Pharmacology/Toxicology
Neurosciences Cardiology Oncology Pharmacology Neuroscience Internal Medicine reproducibility study design data analysis data reporting data integrity quality management open access Cardiovascular medicine |
ISBN | 3-030-33656-5 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | 1. Quality in Non-GxP Research Environment -- 2. Guidelines & Initiatives for Good Research Practice -- 3. Learning from principles of evidence-based medicine to optimize nonclinical research practices -- 4. General Principles of Preclinical Study Design -- 5. Resolving the tension between exploration and confirmation in preclinical biomedical research -- 6. Blinding and Randomization -- 7. Out of control? Managing baseline variability in experimental studies with control groups -- 8. Quality of Research Tools -- 9. Genetic background and sex: impact on generalizability of research findings in pharmacology studies -- 10. Building robustness intro translational research -- 11. Minimum information and quality standards for conducting, reporting, and organizing in vitro research -- 12. Minimum Information in In Vivo Research -- 13. A reckless guide to P-values: Local evidence, global errors -- 14. Electronic Lab Notebooks and Experimental Design Assistants -- 15. Data storage -- 16. Design of meta-analysis studies -- 17. Publishers’ responsibilities in promoting data quality and reproducibility -- 18. Quality governance in biomedical research -- 19. Good Research Practice – Lessons from Animal Care & Use -- 20. Research collaborations and quality in research: foes or friends? -- 21. Costs of implementing quality in research practice. |
Record Nr. | UNINA-9910380750203321 |
Bespalov Anton | ||
Springer Nature, 2020 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Molecular Mechanism of Congenital Heart Disease and Pulmonary Hypertension / / edited by Toshio Nakanishi, H. Scott Baldwin, Jeffrey R. Fineman, Hiroyuki Yamagishi |
Autore | Nakanishi Toshio |
Edizione | [1st ed. 2020.] |
Pubbl/distr/stampa | Singapore, : Springer Nature, 2020 |
Descrizione fisica | 1 online resource (XIII, 406 p. 84 illus., 74 illus. in color.) |
Disciplina | 616.12 |
Soggetto topico |
Cardiology
Pediatrics |
Soggetto non controllato |
Cardiology
Pediatrics Internal Medicine Pulmonary circulation Ductus arteriosus Molecular mechanisms Cellular interactions Stem cell engineering Heart Lung Open access Cardiovascular medicine Paediatric medicine |
ISBN | 981-15-1185-3 |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | PART I: Basic Science of Pulmonary Development and Pulmonary Arterial Disease -- 1 Perspective for Part I -- 2 The alveolar stem cell niche of the mammalian lung -- 3 Lung development and Notch signalling -- 4 Specialized smooth muscle cell progenitors in pulmonary hypertension -- 5 Diverse Pharmacology of Prostacyclin Mimetics: Implications for Pulmonary Hypertension -- 6 Endothelial-to-mesenchymal transition in pulmonary hypertension -- 7 Extracellular vesicles, MicroRNAs and Pulmonary Hypertension -- 8 Roles of Tbx4 in the lung mesenchyme for airway and vascular development -- 9 A lacZ reporter transgenic mouse line revealing the development of pulmonary artery -- 10 Roles of stem cell antigen-1 in the pulmonary endothelium -- 11 Morphological characterization of pulmonary microvascular disease in bronchopulmonary dysplasia caused by hyperoxia in newborn mice -- 12 Involvement of CXCR4 and stem cells in a rat model of pulmonary arterial hypertension -- 13 Ca2+ signal through inositol trisphosphate receptors for cardiovascular development and pathophysiology of pulmonary arterial hypertension -- PART II: Abnormal pulmonary circulation in the developing lung and heart -- 14 Perspective for Part II -- 15 Pathophysiology of Pulmonary Circulation in Congenital Heart Disease -- 16 Development of Novel Therapies for Pulmonary Hypertension by Clinical Application of Basic Research -- 17 Using Patient-Specific Induced Pluripotent Stem Cells to Understand and Treat Pulmonary Arterial Hypertension -- 18 Modeling pulmonary arterial hypertension using induced pluripotent stem cells -- 19 Dysfunction and restoration of endothelial cell communications in Pulmonary Arterial Hypertension: Therapeutic implications -- 20 Inflammatory Cytokines in the Pathogenesis of Pulmonary Arterial Hypertension -- 21 Genotypes and Phenotypes of Chinese Pediatric Patients with Idiopathic and Heritable Pulmonary Arterial Hypertension- Experiences from A Single Center -- 22 Fundamental Insight into Pulmonary Vascular Disease : Perspectives from Pediatric PAH in Japan -- 23 Risk stratification in paediatric pulmonary arterial hypertension -- 24 The Adaptive Right Ventricle in Eisenmenger Syndrome: Potential Therapeutic Targets for Pulmonary Hypertension -- 25 Impaired right coronary vasodilator function in pulmonary hypertensive rat assessed by in vivo synchrotron microangiography -- 26 Relationship between mutations in ENG and ALK1 gene and the affected organs in hereditary hemorrhagic telangiectasia -- 27 A genetic analysis for patients with pulmonary arterial hypertension -- 28 Evaluation and visualization of right ventricle using three dimensional echocardiography -- 29 Pulmonary hypertension associated with post-operative Tetralogy of Fallot -- 30 Microscopic Lung Airway Abnormality and Pulmonary Vascular Disease Associated with Congenital Systemic to Pulmonary Shunt -- 31 Respiratory syncytial virus infection in infants with heart and lung diseases -- PART III: Ductus arteriosus: bridge over troubled vessels -- 32 Perspective for Part III -- 33 The ductus arteriosus, a vascular outsider, in relation to the pulmonary circulation -- 34 Molecular, genetic, and pharmacological modulation of the ductus arteriosus: KATP channels as novel drug targets -- 35 New mediators in the biology of the ductus arteriosus: Lessons from the chicken embryo -- 36 Constriction of the Ductus Arteriosus with KATP Channel Inhibitors -- 37 New insights on how to treat patent ductus arteriosus -- 38 Antenatal Administration of Betamethasone Contributes to Intimal thickening of the Ductus Arteriosus -- 39 Prostaglandin E-EP4-mediated fibulin-1 up-regulation plays a role in intimal thickening of the ductus arteriosus -- 40 Transcriptional profiles in the chicken ductus arteriosus during hatching -- 41 Inhibition of Cyclooxygenase Contracts Chicken Ductus Arteriosus -- 42 Prostaglandin E2 receptor EP4 inhibition constricts the rat ductus arteriosus -- 43 Dilatation of the Ductus Arteriosus by Diazoxide in Fetal and Neonatal Rats -- 44 The Effect of Long-term Administration of Plostaglandin E1 on Morphological Changes in Ductus Arteriosus -- 45 Significance of SGK1 as a protein kinase transcriptionally regulated by ALK1 signaling in vascular endothelial cells -- 46 Fabrication of Implantable Human Arterial Graft by Periodic Hydrostatic Pressure -- 47 Optimum preparation of Candida albicans cell wall extra (CAWE) for the mouse model of Kawasaki disease -- PART IV: Development and Regeneration of the Cardiovascular System -- 48 Perspective for Part IV -- 49 Advances in the second heart field -- 50 Novel cardiac progenitors for all components of the heart except for the right ventricle -- 51 Regional and TBX5-dependent gene expression in the atria: Implications for pulmonary vein development and atrial fibrillation -- 52 The Endocardium as a Master Regulator of Ventricular Trabeculation -- 53 The Role of Alternative mRNA Splicing in Heart Development -- 54 Progress in the Generation of Multiple Lineage Human-iPSC-derived 3D Engineered Cardiac Tissues for Cardiac Repair -- 55 Quantification of contractility in stem cell derived cardiomyocytes -- 56 A neurotrophic factor receptor GFRA2, a specific surface antigen for cardiac progenitor cells, regulates the process of myocardial compaction -- 57 Cardiac cell specification and differentiation by the defined factors -- 58 A Temporo-Spatial Regulation of Sema3c is Essential for Interaction of Progenitor Cells during Cardiac Outflow Tract Development -- 59 Spatiotemporally restricted developmental alterations in the anterior and secondary heart fields cause distinct conotruncal heart defects -- 60 Significance of transcription factors in the mechanisms of great artery malformations -- 61 The different c-kit expression in human induced pluripotent stem (iPS) cells between with feeder cells and without feeder cells -- 62 Establishment of induced pluripotent stem cells from immortalized B cell lines and their differentiation into cardiomyocytes -- 63 Establishment of an in vitro LQT3 model, using induced pluripotent stem cells from LQT3 patient-derived cardiomyocytes -- 64 Genetic Assessments for clinical courses of Left ventricle noncompaction -- 65 Elucidating the pathogenesis of congenital heart disease in the era of next-generation sequencing. |
Record Nr. | UNINA-9910380729503321 |
Nakanishi Toshio | ||
Singapore, : Springer Nature, 2020 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|